articleTop 1% cited

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

European Journal of Pharmacology · 2002 · Vol. 441(3) · pp. 137–140

Shaun Jordan✉(Otsuka (United States))Vuk Koprivica(Otsuka (United States))Ruoyan Chen(Otsuka (United States))Katsura Tottori(Otsuka (Japan))Tetsuro Kikuchi(Otsuka (Japan))C. Anthony Altar(Otsuka (United States))

View via DOI Publisher page

Receptor Mechanisms and Signaling Neurotransmitter Receptor Influence on Behavior Neuropeptides and Animal PhysiologyAripiprazolePartial agonistDopamine receptor D2AgonistChemistryPharmacologyReceptorChinese hamster ovary cellInternal medicineEndocrinology

MeSH terms

AripiprazoleAnimalsBinding SitesDose-Response Relationship, DrugCricetinaeHumansPiperazinesReceptors, SerotoninAntipsychotic AgentsQuinolonesSerotonin Receptor AgonistsReceptors, Serotonin, 5-HT1

Citations

505

FWCI

10.62

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials